Literature DB >> 14905116

Primary parathyroid hypertrophy and hyperplasia; a review of 11 cases at the Massachusetts General Hospital.

B CASTLEMAN, O COPE.   

Abstract

Entities:  

Keywords:  PARATHYROID DISEASES; PARATHYROID GLAND/surgery

Mesh：

Year:  1951        PMID： 14905116

Source DB:  PubMed          Journal:  Bull Hosp Joint Dis


× No keyword cloud information.
  8 in total

1.  Primary chief-cell hyperplasia of the parathyroid glands: a new entity in the surgery of hyperparathyroidism.

Authors:  O COPE; W M KEYNES; S I ROTH; B CASTLEMAN
Journal:  Ann Surg       Date:  1958-09       Impact factor: 12.969

2.  Carcinoma of the parathyroid glands: 4 cases among 148 patients with hyperparathyroidism.

Authors:  O COPE; G L NARDI; B CASTLEMAN
Journal:  Ann Surg       Date:  1953-10       Impact factor: 12.969

3.  The ultrastructure of primary water-clear cell hyperplasia of the parathyroid glands.

Authors:  S I Roth
Journal:  Am J Pathol       Date:  1970-11       Impact factor: 4.307

4.  Parathyroid pathology: its relation to choice of operation for hyperparathydroidism.

Authors:  C B Esselstyn
Journal:  World J Surg       Date:  1977-11       Impact factor: 3.352

5.  Parathyroid transplantation.

Authors:  S A Wells; J A Stirman; R M Bolman
Journal:  World J Surg       Date:  1977-11       Impact factor: 3.352

6.  Polyclonal origin of parathyroid tumors is common and is associated with multiple gland disease in primary hyperparathyroidism.

Authors:  Yuhong Shi; Pedram Azimzadeh; Sarada Jamingal; Shannon Wentworth; Janice Ferlitch; James Koh; Nariman Balenga; John A Olson
Journal:  Surgery       Date:  2018-01       Impact factor: 3.982

7.  Surgical management of hyperparathyroidism due to primary hyperplasia.

Authors:  C A Wang; B Castleman; O Cope
Journal:  Ann Surg       Date:  1982-04       Impact factor: 12.969

8.  The rapid identification of "normal" parathyroid glands by the presence of intracellular fat.

Authors:  S I Roth; M J Gallagher
Journal:  Am J Pathol       Date:  1976-09       Impact factor: 4.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.